FDA
approval
· 2024-07-26
FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Fresenius Kabi USA, LLC)
Summary
FDA approved a supplemental application for a ketorolac tromethamine product by Fresenius Kabi USA, LLC under the ANDA pathway. This action adds a generic ketor…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)